Beihai Galaxy Biotechnology Investment Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
1. Explanation of the Appointment of Sponsor Securities Firm
On June 5, 2023, the Company received the Shenzhen Stock Exchange's (hereinafter referred to as "SZSE") decision on the termination of the Company's stock listing (Shenzhen Stock Exchange [2023] No. 475). The SZSE decided to terminate the listing of the Company's stock. After the termination of the stock listing, the Company's shares will be transferred to the delisting sector managed by the National Equities Exchange and Quotations (NEEQ).